Company Watch

ReaMetrix releases Accuford reagent kit

Our News Bureau - Bangalore

ReaMetrix and Millipore India released the Accuford Tri-TStat reagent kit. Through an exclusive distribution partnership in the Indian market, ReaMetrix and Millipore India will bring a new generation of affordable diagnostics to the public. RMX has developed this product entirely in India to benefit Indian market. The Tri-TSat reagent kit is the first product in the Accuford brand of affordable diagnostics, which will be developed and manufactured in India by ReaMetrix and distributed by Millipore-India. The Tri-TSat reagent kit enables a critical test for management of AIDS patients to be available at a very reasonable cost. The affordability of Tri-TSat over imported reagents allows physicians to measure the ravaging effects of HIV on patients of immune system and effectiveness of drug therapy.

"We are impressed with the quality and availability of these reagents at this price point that has allowed us to significantly reduce cost of these tests from Rs 2000 to as less as Rs 500. The local availability of these reagents will also assure freshness increasing the reliability of the tests," says Dr Sujay Prasad, Pathologist of Anand Diagnostic Laboratory.

The Accuford brand aims to leverage strengths of Millipore India and ReaMetrix to create and distribute diagnostic products that will address significant public health problems in India. There will be a release of a series of products in the next two years which will drive significant employment and marketing opportunities. Bala S Manian, Director of ReaMetrix, says, "We are focusing on value arbitrage rather than cost arbitrage. ReaMetrix is committed to leverage the strengths of Indian scientists to deliver enormous value in the fields of clinical diagnostics and life science research. We are making business with minimal profit capitalising on the local resources. We import science and implement it here."

Sudir Kant, President of Millipore, said, "At present we are focussing on the metropolis and then are planning to eventually make it available for all. With extended shelf life and barring refrigeration of the product it comes handy to all." Commenting on the products in pipeline, Balan said, "We are developing a system called a multiplex test which enables easy diagnosis of various diseases commonly found in India."